CXCL12 and neoplasm: Abemaciclib inhibits restoration of tumor vasculature post irradiation by inhibiting HIF-1 and SDF-1 expression in the tumor microenvironment thereby mitigating radiation-induced vasculogenesis (Naz et al. 2019).